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Abstract
Dynamic models of metabolism can be useful in identifying potential drug targets, especially in unicellular organisms. A
model of glycolysis in the causative agent of human African trypanosomiasis, Trypanosoma brucei, has already shown the
utility of this approach. Here we add the pentose phosphate pathway (PPP) of T. brucei to the glycolytic model. The PPP is
localized to both the cytosol and the glycosome and adding it to the glycolytic model without further adjustments leads to
a draining of the essential bound-phosphate moiety within the glycosome. This phosphate ‘‘leak’’ must be resolved for the
model to be a reasonable representation of parasite physiology. Two main types of theoretical solution to the problem
could be identified: (i) including additional enzymatic reactions in the glycosome, or (ii) adding a mechanism to transfer
bound phosphates between cytosol and glycosome. One example of the first type of solution would be the presence of a
glycosomal ribokinase to regenerate ATP from ribose 5-phosphate and ADP. Experimental characterization of ribokinase in
T. brucei showed that very low enzyme levels are sufficient for parasite survival, indicating that other mechanisms are
required in controlling the phosphate leak. Examples of the second type would involve the presence of an ATP:ADP
exchanger or recently described permeability pores in the glycosomal membrane, although the current absence of
identified genes encoding such molecules impedes experimental testing by genetic manipulation. Confronted with this
uncertainty, we present a modeling strategy that identifies robust predictions in the context of incomplete system
characterization. We illustrate this strategy by exploring the mechanism underlying the essential function of one of the PPP
enzymes, and validate it by confirming the model predictions experimentally.
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Introduction
Human African trypanosomiasis, or sleeping sickness, is a lethal
disease caused by the protozoan parasite Trypanosoma brucei [1,2].
Current drugs against trypanosomiasis are difficult to administer,
unacceptably toxic, and relatively expensive when considering the
impoverished state of most patients [3]. The search for new
promising drug targets has been supported by a series of
computational models, focusing on energy production via the
glycolytic pathway [4–8]. This pathway has been considered to be
a particularly promising target for new drugs, as a 50% reduction
in ATP production in T. brucei by inhibitors of glycolysis was
demonstrated to be sufficient to kill the parasites [9].
In this paper, we extended this model of glycolysis with a
description of the pentose phosphate pathway (PPP), another
essential [10,11] maintenance pathway that generates reducing
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equivalents in the form of NADPH that are used in the cells’
protection against oxidative stress and thus provides a metabolic
link to another important drug target in trypanosomes [12].
Bloodstream form T. brucei relies on the PPP as the primary source
of NADPH, in contrast to procyclic T. brucei which can also
produce NADPH via malic enzyme [13].
Kinetic models of metabolism, such as those constructed of T.
brucei glycolysis, include kinetic parameters that are uncertain for a
variety of reasons, such as measurement errors or lack of data. We
have previously shown the importance of taking uncertainty of
these parameter values into account [8]. This approach can
demonstrate which model behaviors are robust to the uncertainty,
helping to indicate fragilities in the model and highlighting areas in
need of more detailed experimental characterization. When
introducing the PPP to the model of glycolysis we face the
additional challenge of uncertainty in the model topology itself; we
do not know for sure which reactions are active in the context of
this pathway. Again an explicit consideration of this uncertainty in
the model construction reveals robust behavior and indicates gaps
in our knowledge of T. brucei metabolism. We illustrate the
consequences of this uncertainty, and the robust predictions that
are still possible, by exploring model behavior under various
physiological conditions (different levels of oxidative stress and of
external glucose concentration) and characterizing the effects of
the inhibition of 6-phosphogluconate dehydrogenase (6PGDH), an
essential enzyme of the pentose phosphate pathway, proposed as
another potential drug target [14].
Results
Simple modeling of the PPP creates a glycosomal
phosphate ‘‘leak’’
The existing mathematical model of glycolysis in T. brucei [8]
was extended to include the reactions from the pentose phosphate
pathway (PPP). In T. brucei, the PPP is localized to both the cytosol
and glycosomes, based on subcellular localization studies [15–17],
proteomic analysis [18,19] and subcellular targeting-sequence-
based predictions [20]. Figure 1 gives an overview of the models
considered in this paper, while the stoichiometry and kinetic
parameters are described in Table 1 and S1, respectively.
To provide glucose 6-phosphate (Glc-6-P) to the cytosolic
glucose 6-phosphate dehydrogenase (G6PDH), a trace amount of
cytosolic hexokinase was added in models B–D. An alternative
solution, where transport of Glc-6-P over the glycosomal
membrane is allowed, gave similar results. Fractionation studies
that suggest an exclusively glycosomal localization of hexokinase
activity [21] are insufficiently sensitive to discriminate a trace
amount of cytosolic hexokinase. Moreover, enzymes targeted to
the glycosome can be fully folded in the cytosol, which leaves room
for a small, residual activity in this compartment. We therefore
decided to explore the model behavior in the presence of cytosolic
hexokinase in the following analyses, yet acknowledge that this
choice is somewhat arbitrary. A reaction utilizing cytosolic Glc-6-P
was added in models B–D, as absence of this reaction resulted in
accumulation of Glc-6-P in the cytosol (25% of the models have a
cytosolic Glc-6-P concentration over 20 mM, in contrast to a
measured steady-state value of 2.6 mM). This reaction primarily
represents the use of Glc-6-P in other cytosolic pathways, such as
the glycosylation of proteins [22].
The model of glycolysis (Figure 1B, model A) has a conserved
sum of phosphorylated metabolites in the glycosome, consisting of
ATP, ADP and glycolytic intermediates (Table 2). Extension of the
glycolysis model with the PPP (Figure 1B, model B) introduces a
drain from this moiety of phosphorylated glycosomal compounds.
While the extension with the PPP adds metabolites in the
glycosome that are derived from Glc-6-P, these phosphorylated
PPP intermediates are prevented from re-entering glycolysis as two
key enzymes of the non-oxidative PPP—ribulose-5-phosphate
epimerase [23] and transketolase [17,23]—are not expressed in
the bloodstream form of the parasite. This renders ribose 5-
phosphate (Rib-5-P) as the end product of the PPP according to
the classical scheme, and leads to a lethal drainage of phosphates
from the previously conserved moiety (Figure 2). This phosphate
‘‘leak’’ only entails bound phosphate, and not inorganic phos-
phate, which is independent of the conserved moiety. This leak of
phosphates from the conserved moiety of bound phosphates is only
observed in the glycosome, as the bound phosphates are not
conserved in the cytosol, where there is a net production of ATP
via pyruvate kinase. Model B is therefore an obviously non-
physiological model and was not investigated further. The
phosphate leak is an effect of the stoichiometry of the model and
not the enzyme kinetics: the formal proof of this is that there exists
no elementary mode (Table S2) for model B with a flux through
the PPP.
Exploring solutions to the phosphate leak
There is uncertainty as to how this glycosomal phosphate leak is
prevented in the parasite. Two types of solution can be considered:
(i) maintaining the conserved moiety of phosphorylated metabo-
lites by including additional reactions in the glycosome, or (ii)
transferring phosphorylated metabolites over the glycosomal
membrane. No a priori knowledge exists on balancing of bound
phosphates in the glycosome that would convincingly support
either solution over the other.
First type of solution: Maintaining the conserved moiety
For the first type of solution, a stoichiometric analysis of all
known and predicted glycosomal enzymes [18–20] was performed
to indicate what additional reactions in the glycosome can recover
the bound-phosphate lost via Rib-5-P (Tables S3, S4, Figure S1).
Only ribokinase, which has a C-terminal PTS-1 sequence that
Author Summary
Mathematical models have been valuable tools for
investigating the complex behaviors of metabolism. Due
to incomplete knowledge of biological systems, these
models contain inevitable uncertainty. This uncertainty is
present in the measured or estimated parameter values,
but also in the structure of the metabolic network. In this
paper we increase the coverage of a particularly well
studied model of glucose metabolism in Trypanosoma
brucei, a tropical parasite that causes African sleeping
sickness, by extending it with an additional pathway in
two compartments. During this modeling process we
highlighted uncertainties in parameter values and network
structure and used these to formulate new hypotheses
which were subsequently tested experimentally. The
models were improved with the experimentally derived
data, but uncertainty remained concerning the exact
topology of the system. These models allowed us to
investigate the effects of the loss of one enzyme, 6-
phosphogluconate dehydrogenase. By taking uncertainty
into account, the models demonstrated that the loss of
this enzyme is lethal to the parasite by a mechanism
different than that in other organisms. Our methodology
shows how formally introducing uncertainty into model
building provides robust model behavior that is indepen-
dent of the network structure or parameter values.
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localizes it to the glycosome, is able to support a steady-state flux
through the PPP without the requirement of additional reactions
that are not known or predicted to be localized to the glycosome.
The addition of hypothetical reactions in the glycosome can
provide alternative solutions to the phosphate leak, however, the
ribokinase solution is representative of this class of solutions where
the bound phosphate is balanced within the glycosome and the
moiety of bound phosphates is conserved. This solution requires
Figure 1. Schematic overview of the models used for simulation. (A) Detailed scheme of the modeled metabolic pathways. The numbered
arrows correspond to reactions from Table 1. Extensions to the original model of glycolysis are indicated by colored shapes. Boundary metabolites are
in bold, glycosomal Rib-5-P is a boundary metabolite in model C and D. (B) Schematic overview of the different models, each consisting of a unique
combination of the colored modules described in (A) and Table 1. Model C and D can alternatively utilize fructose (model Cfru and Dfru), but this
branch is switched off unless specifically mentioned.
doi:10.1371/journal.pcbi.1003371.g001
Modelling Metabolism in Trypanosoma brucei
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ribokinase to operate in the direction of ribose and ATP
production, which is not favored thermodynamically in standard
conditions. With an equilibrium constant of 0.0036 (in the
direction of ribose formation, [24]) ribokinase would require an
almost 300-fold accumulation of Rib-5-P over ribose in the
glycosome, indicating that ribose in the glycosome would be in the
mM range and Rib-5-P in the mM range. This ratio can be further
improved by a low ATP/ADP ratio. A similar solution, however,
has already been exploited with regard to glycerol kinase at the
onset of anaerobiosis. In response to loss of the mitochondrial
alternative oxidase reaction under these conditions, trypanosomal
glycerol kinase runs in the direction of glycerol and ATP
production, as glycerol 3-phosphate accumulates and a low
ATP/ADP ratio is maintained in the glycosome [25].
Table 1. Model stoichiometry by modules and their subsequent reactions.
Module No. Reaction name Reaction stoichiometry
Glycolysis 1 GlcTplasma membrane Glcout«Glcc
2 GlcTglycosomal membrane Glcc«Glcg
3 HXKg Glcg+ATPg«Glc-6-Pg+ADPg
4 PGI Glc-6-Pg«Fru-6-Pg
5 PFK Fru-6-Pg+ATPg«Fru-1,6-BPg+ADPg
6 ALD Fru-1,6-BPg«DHAPg+GA-3-Pg
7 TPI DHAPg«GA-3-Pg
8 GAPDH GA-3-Pg+NAD+g+Pig«1,3-BPGAg+NADHg
9 PGK 1,3-BPGAg+ADPg«3-PGAg+ATPg
10 PGAT 3-PGAg«3-PGAc
11 PGAM 3-PGAc«2-PGAc
12 ENO 2-PGAc«PEPc
13 PYK PEPc+ATPc«Pyrc+ADPc
14 PyrT PyrcRPyrout
15 GDH DHAPg+NADHg«NAD+g+Gly-3-Pg
16 DHAP:Gly-3-P antiporter DHAPc+Gly-3-Pg«DHAPg+Gly-3-Pc
17 GPO Gly-3-Pc+0.5 O2RDHAPc
18 GK Gly-3-Pg+ADPg«Glyout+ATPg
19 ATP utilization ATPcRADPc
20 AKg 2 ADPg«ATPg+AMPg
21 AKc 2 ADPc«ATPc+AMPc
Cytosolic extension 22 G6P utilization Glc-6-Pc«Glcc+Pic
23 HXKc Glcc+ATPc«Glc-6-Pc+ADPc
24 G6PDH Glc-6-Pc+NADP+c«6-PGLc+NADPHc
25 PGL 6-PGLc«6-PGc
26 6PGDH 6-PGc+NADP+c«Rul-5-Pc+NADPHc+CO2
27 PPI Rul-5-Pc«Rib-5-Pc
28 NADPH utilization NADPHc«NADP+c
29 TR TS2,c+NADPHc«T(SH)2,c+NADP+c
30 TOX T(SH)2,cRTS2,c
Glycosomal extension 31 G6PDH Glc-6-Pg+NADP+g«6-PGLg+NADPHg
32 PGL 6-PGLg«6-PGg
33 6PGDH 6-PGg+NADP+g«Rul-5-Pg+NADPHg+CO2
34 PPI Rul-5-Pg«Rib-5-Pg
35 NADPH utilization NADPHg«NADP+g
Model C extension 36 RK Rib-5-Pg+ADPg«Ribg+ATPg
Model D extension 37 ATP:ADP antiporter ATPc+ADPg«ATPg+ADPc
Fructose growth 38 FruTplasma membrane Fruout«Fruc
39 FruTglycosomal membrane Fruc«Frug
40 HXK(fru)g Frug+ATPg«Fru-6-Pg+ADPg
Bold characters indicate external metabolites which are kept fixed. Other metabolites are internal variables of the system.
doi:10.1371/journal.pcbi.1003371.t001
Modelling Metabolism in Trypanosoma brucei
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Model B was therefore extended with a glycosomal ribokinase,
generating model C (Figure 1), which represents a solution where
the glycosomal conserved moiety of bound phosphates is restored
(Table 2, moiety 9). In order to provide kinetic parameters for
model C, the enzyme kinetics of heterologously expressed T. brucei
ribokinase were characterized and used to update the model (see
Table S1 for determined kinetic parameters). Dynamic simulations
of the extended model subsequently indicated the feasibility of
ribokinase as a solution, since it allows metabolic fluxes through all
branches (Figure S2 and Table S2).
When ribokinase is indeed responsible of maintaining the
phosphate balance in the glycosomes, its presence is expected to be
essential for parasite survival. To investigate this hypothesis, a
genetic mutant (RKRNAi) was generated to knockdown the levels of
ribokinase transcript by RNA interference. However, no growth
phenotype was observed (Figure S3). Attempts to generate a gene
knockout of ribokinase, surprisingly, failed in spite of numerous
rounds of transfection. A conditional knockout was generated with
inducible expression of an exogenous copy of the T. brucei
ribokinase gene. While non-induced growth resulted in depletion
of ribokinase, again no growth phenotype could be observed, even
if the ectopic copy was switched off. It was concluded that
ribokinase activity is essential but that residual levels in RKRNAi
and leaky expression in the conditional knockout were sufficient to
fulfill this essential role.
Additionally, the requirement of a low ribose/Rib-5-P ratio to
catalyze the formation of ribose by ribokinase predicts that ribose
should be toxic to the parasites (Figure S4), in a similar way to
glycerol that can prevent glycerol kinase from working in the
reverse direction. However, incubation of parasites with ribose up
to 30 mM for over 72 hours was non-lethal. From these results
and the genetic mutants, it was concluded that ribokinase is
unlikely the sole glycosomal enzyme responsible for maintaining
the phosphate balance. Other kinases, such as arginine kinase [26]
and phosphoenolpyruvate carboxykinase (PEPCK), are also
present within the glycosome and bound phosphate homeostasis
could involve a large and redundant network of contributing
metabolic pathways. While uncertainty remains on which enzymes
would be involved in preventing the phosphate leak by restoring
the conserved moiety of phosphorylated metabolites, model C
represents a generic representation of such a solution. Continued
analysis of this model can, therefore, still provide insight into the
effects of such a solution even in the absence of a specific
individual enzyme.
Figure 2. Phosphate leak in model with PPP. Time course
simulation of model B, in which the reactions of the glycosomal PPP are
switched on at t=0 by increasing their Vmax value from zero to the
value given in Table S1. Glce is 5 mM and kTOX=2 ml?min
21?mg
protein21. Solid lines indicate medians, shaded areas show interquartile
ranges. Fluxes (J) are plotted on the left y-axis and are indicative of
glucose uptake (GlcTplasma membrane), glycerol (GK) and pyruvate
production (PyrT) and the two branches of pentose phosphate
pathways (G6PDHc/g). The sum of bound phosphates in the glycosome
(SPg), as exists in the model of glycolysis (Table 2, moiety 5), is plotted
on the right y-axis. Within 25 minutes, all bound phosphates within the
glycosome are depleted and all metabolic fluxes subsequently drop to
zero.
doi:10.1371/journal.pcbi.1003371.g002
Table 2. Conserved moieties in the four models of Figure 1.
Model Moieties Metabolites
A 1 ATPg+ADPg+AMPg
2 ATPc+ADPc+AMPc
3 NADHg+NAD+g
4 Gly3-Pc+DHAPc
5 Glc-6-Pg+Fru-6-Pg+2 Fru-1,6-BPg+DHAPg+GA-3-Pg+1,3-BPGAg+Gly-3-Pg+2 ATPg+ADPg
B 1,2,3,4
6 NADPHg+NADP+g
7 NADPHc+NADP+c
8 TS2,c+T(SH)2,c
C 1,2,3,4,6,7,8
9 Glc-6-Pg+Fru-6-Pg+2 Fru-1,6-BPg+DHAPg+GA-3-Pg+1,3-BPGAg+Gly-3-Pg+2 ATPg+ADPg+6-PGg+6-PGLg+Rul-5-
Pg+Rib-5-Pg
D 1,2,3,4,6,7,8
Where moieties are present in multiple models, only the number is indicated. Moieties 1–4 are conserved in all four model versions. Moieties 6–8 are a result of the
extension with the pentose phosphate pathway. Moiety 9 is a modified version of moiety 5, now including the phosphorylated metabolites of the pentose-phosphate
pathway. The latter appears when the glycosomal PPP is completed with ribokinase. When the glycosomal PPP is linked to ATP transport instead, moiety 5 disappears
altogether.
doi:10.1371/journal.pcbi.1003371.t002
Modelling Metabolism in Trypanosoma brucei
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Second type of solution: Transferring phosphates over
the glycosomal membrane
An alternative solution to the phosphate leak requires transfer-
ring bound-phosphates over the glycosomal membrane. This can
be achieved by the presence of a single ATP:ADP antiporter
operative across the glycosomal membrane, analogous to the yeast
peroxisomal adenine nucleotide transporter [27]. Model D was
generated by the addition of an ATP:ADP antiporter to model B
(Figure 1), and stoichiometric analysis of model D showed the
absence of a conserved moiety of phosphorylated glycosomal
metabolites (Table 2).
Dynamic analysis of model D showed that the absence of the
conservation constraint on phosphorylated metabolites in the
glycosome introduced a risk of high accumulation of these
metabolites. The autocatalytic design of glycolysis means that
surplus ATP produced in the later steps of glycolysis can fuel the
first reactions in a positive feedback loop. This ‘‘turbo design’’ [28]
is controlled in most organisms by additional negative feedback
regulation, e.g. inhibition of PFK by PEP [29]. Trypanosomes lack
such regulation, but dynamic modeling supported by direct
experimentation revealed that the glycosomal localization of part
of glycolysis prevents the turbo effect in trypanosomes [30,31].
Glucose is predicted to be lethal for glycosome deficient
bloodstream forms [32], while procyclic forms, which can grow
on both glucose and proline, could be rescued by the removal of
sugars from the medium [32], or by the ablation of hexokinase
[33]. Simulations of model D indicate that the presence of an
ATP:ADP antiporter mimics the absence of a glycosome, with a
high risk of sugar-phosphate accumulation (Figure 3). While the
presence of the PPP can partly rescue a model with the ATP:ADP
antiporter from accumulation of sugar-phosphates (Figure 3B–C,
compare model A+AAT and D), a high risk of accumulation
remains when the antiporter is too active (Figure 3D–E). It has
been shown experimentally in procyclic trypanosomes that such
accumulation occurs only when enzymes are mislocalized, and this
is detrimental for the cells [31]. Other types of transporters,
including recently described pores in the glycosomal membrane
[34], facilitating a net transport of phosphorylated compounds into
the glycosome gave similar results, while the absence of known
genes encoding these transporters impedes further testing of this
hypothesis by genetic manipulation.
The two hypothesized solutions to the phosphate leak are both
theoretically able to restore a glycolytic and PPP flux. Although
current available knowledge is insufficient to explicitly exclude one
of the two types of solutions, further analysis of the two models can
still give us valuable insights on for instance 6PGDH inhibition,
Figure 3. ATP:ADP antiporter mimics turbo-state. (A) Overview of the models used in this figure. Model A and D are from Figure 1, model A–
glyc is model A without glycosomal localization, as described in [31], model A+AAT is model A with an ATP:ADP antiporter. (B–C) Steady-state
concentrations of glycosomal Glc-6-P and Fru-1,6-BP are depicted in the various models. (D) Increasing the activity of the ATP:ADP antiporter
(Vmax,ATP:ADP antiporter) in model D leads to a high risk of accumulation of hexose phosphates. The green line indicates the concentration of Fru-1,6-BP
in the original model of glycolysis (17.2 mM, panel C, model A). Glce in this simulation is 25 mM. (E) Time course simulation of model D at 25 mM Glce
and various values for the Vmax,ATP:ADP antiporter parameter. Plotted is the concentration of glycosomal phosphates (SP similar as in Figure 2, moiety 5
in Table 2). ATP:ADP antiporter activity values below 1 nmol?min21?mg protein21 result in depletion of glycosomal phosphates (cf. Figure 2).
kTOX= 2 ml?min
21?mg protein21 in all models. Solid lines indicate medians, shaded areas and error bars show interquartile ranges, as derived from the
uncertainty modeling.
doi:10.1371/journal.pcbi.1003371.g003
Modelling Metabolism in Trypanosoma brucei
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while not ignoring the uncertainty involved. We demonstrate this
below.
Predictive behavior using the extended models of
trypanosome glucose metabolism
Dynamic simulations using both models, containing either of
the two theoretical solutions to the phosphate-leak problem,
showed that oxidative stress regulates the flux through the PPP
(Figure 4A), in line with measured increases in the flux through the
PPP in the related species T. cruzi upon induced oxidative stress
[35]. Low oxidative stress (kTOX=2 mLNmin
21Nmg protein21)
represents a healthy proliferating trypanosome and results in a
low PPP flux, supported by the experimental observation that
almost all consumed glucose is excreted as either pyruvate or
glycerol [36,37]. A sudden burst of oxidative stress was simulated
by almost completely (99%) oxidizing the pools of trypanothione
and NADPH and subsequently allowing the model to reach steady
state. The parasite was able to restore its redox balance in about
one minute (Figure 4B). This experiment simulates an extreme
level of oxidative stress, but if in reality the pools never become
99% oxidized, the PPP can respond even faster.
It has previously been proposed that inhibition of the third
enzyme of the PPP, 6-phosphogluconate dehydrogenase
(6PGDH), should be lethal to trypanosomes [38]. In Drosophila
[39,40], yeast [41] and mammalian cancer cells [42], lethality of
6PGDH inhibition is based on the inhibition of glycolysis by the
accumulation of 6-phosphogluconate (6-PG). Inhibition of
6PGDH results in accumulation of its substrate 6-PG, and as a
potent inhibitor of phosphoglucose isomerase (PGI) [43], 6-PG
subsequently inhibits the conversion from glucose 6-phosphate
(Glc-6-P) to fructose 6-phosphate. With Glc-6-P then instead
directed towards the PPP, 6-PG accumulates to even higher levels,
ultimately inhibiting the ATP producing glycolytic pathway. In
Drosophila and yeast, this lethal phenotype can be rescued by
additional loss of G6PDH, completely shutting down the PPP and
as such preventing accumulation of 6-PG [40,41]. Growth on
alternative hexoses such as fructose, bypassing the PGI reaction
and as such preventing inhibition of glycolysis, was shown to
rescue 6PGDH deficient cancer cells [42]. A similar route to
lethality of 6PGDH inhibition via PGI inhibition was hypothesized
for T. brucei [10], but no experimental proof exists to corroborate
this hypothesis. Alternatively, the reduced PPP flux in 6PGDH
inhibited trypanosomes potentially renders the parasites more
susceptible to oxidative stress. To analyze these two hypotheses,
the activity of 6PGDH was investigated in both models C and D.
6PGDH inhibition in both models resulted in the accumulation
of 6-PG as anticipated (Figure 5A–B). Both models gave very
similar results, as the only major difference is that glycosomal 6-
PG in model C is restricted to 45 mM due to the constraint of the
conserved moiety of phosphorylated metabolites. Highly oxidative
conditions resulted in a cytosolic 6-PG accumulation that started
at lower 6PGDH inhibitions, as the cytosolic PPP flux is activated
to provide the NADPH required by trypanothione reductase.
Only when the 6PGDH activity was decreased by more than 95%
was glycolysis reduced to a negligible flux. To observe the effects of
accumulated 6-PG on PGI in isolation from other effects, model A
with a 6-PG sensitive PGI was simulated at different 6-PG levels. A
50% reduction in glycolytic flux is lethal to the parasite [9], but
this level of inhibition was reached only at 6-PG levels of around
500 mM (Figure 5C). In model C, the conserved moiety of bound
phosphates restrict the glycosomal 6-PG level to only 45 mM
(Figure 5A), while in model D such high accumulation of
glycosomal 6-PG occurs in combination with far more extreme
accumulation of cytosolic 6-PG (Figure 5B). Neither model
therefore supports the PGI inhibition hypothesis as the explana-
tion of the lethality 6PGDH inhibition in T. brucei.
The second hypothesis initially proposed posits that 6PGDH
inhibition is lethal due to the reduced flux through the PPP and the
associated increased sensitivity for oxidative stress. In both models,
the simulation of 6PGDH inhibition demonstrates how the cell’s
ability to cope with oxidative stress is strongly affected, as the flux
through trypanothione reductase is inhibited when the activity of
6PGDH is reduced by more than 50% (Figure 5A–B). A third
hypothesis introduced in model C reveals that the accumulation of
glycosomal 6-PG depletes other bound phosphates within the
glycosome, thus inhibiting the glycolytic flux. Sensitivity to oxidative
stress, and the depletion of bound phosphates from the conserved
moiety, could therefore both explain loss of viability due to ablation
of 6PGDH. While accumulation of the toxic lactone precursor of 6-
PG through product inhibition of the lactonase enzyme is another
possibility, the high equilibrium constant of this reaction renders it
insensitive to its product [44]. Finally, a reduced production of the
nucleotide precursor Rib-5-P by the PPP could explain the 6PGDH
inhibition lethality.
Figure 4. Simulations of oxidative stress in model C. (A) The steady state flux through the cytosolic pentose phosphate pathway in model C as
a function of the oxidative stress by varying the kinetic constant kTOX. (B) Fluxes through the cytosolic PPP enzymes as a function of time upon
sudden oxidative stress. During the whole time-course, kTOX=2 ml?min
21 ? mg protein21. The system is removed from steady state at t=0, by setting
99% of the NAD(P)H and trypanothione pools to the oxidized form. Shown is the relaxation of the cytosolic PPP fluxes. Solid lines indicate medians,
shaded areas show interquartile ranges. Near identical results were obtained for model D (Figure S5).
doi:10.1371/journal.pcbi.1003371.g004
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RNA interference confirms that 6PGDH is essential, but
lethality is not due to inhibition of glycolysis
The predictions from the modeling were tested experimentally.
A genetic mutant in which the 6PGDH transcript is knocked down
by RNA interference (6PGDHRNAi) yielded reduced levels and
activities of 6PGDH (Figure 6A) and subsequent cell death,
confirming the severe effects of 6PGDH inhibition observed
during model simulations. Antibodies against 6PGDH also
revealed this enzyme to be distributed to both cytosol and to a
lesser degree the glycosome (Figure 6B).
The 6PGDH activity measurements indicate that the growth of
the parasites is affected when the 6PGDH activity is reduced by
less than 50% in the first 24 hours. Even after 72 hours, 15% of
the 6PGDH activity remains. This suggests that the first and third
hypotheses, i.e. PGI inhibition and the depletion of the bound
phosphate moiety, are unlikely. 6PGDHRNAi parasites could not
be rescued by the addition of 0.5 mM ribose, as an alternative
pathway to Rib-5-P, suggesting that the availability of Rib-5-P for
nucleotide biosynthesis was not responsible for the lethal
phenotype.
To test whether the proposed feedback loop related to inhibition
of PGI by accumulating 6-PG we tested how the 6PGDHRNAi
trypanosomes behaved when grown in fructose, a glycolytic
substrate [11,37,45] that can enter the pathway after the PGI step,
which was previously shown to rescue growth of 6PGDH deficient
cancer cells [42].
Model C and D were both extended using the fructose
transporter and its subsequent utilizing reactions (Figure 1), using
parameter values from the literature (Table S1). The rate equation
of hexokinase was adapted to describe the substrate competition of
glucose and fructose. Steady-state calculation of the fructose
versions of the models (model Cfru and Dfru) predict that growth of
parasites is supported on fructose, although the lethal effect of
6PGDH inhibition could not be averted by using this substrate
(Figure S7). This again indicates that the lethal effect of 6PGDH
Figure 5. Simulations of 6PGDH inhibition and 6-PG accumulation. (A–B) The effects of inhibition of 6PGDH on 6-PG concentrations and
metabolic fluxes were simulated by reducing Vmax,6PGDH in model C and D at high oxidative stress (kTOX= 200 ml?min21?mg protein21). Simulations at
low oxidative stress (kTOX=2 ml?min
21?mg protein21) are shown in Figure S6. ATP production flux as steady-state flux through PFK is indicated in red,
while trypanothione reductase steady-state flux is indicated in yellow, both plotted on the left y-axis. Steady-state concentration of cytosolic (blue)
and glycosomal (green) 6-phosphogluconate are plotted on the right y-axis. Shaded areas indicate interquartile ranges. (C) Steady-state flux through
glycolysis as a function of the glycosomal 6-PG concentration in model A. A glycosomal 6-PG concentration of around 500 mM reduces the glycolytic
flux by 50%.
doi:10.1371/journal.pcbi.1003371.g005
Figure 6. Ablation of 6PGDH. (A) Effect of 6PGDH ablation on the
growth rate. A non-induced 6PGDHRNAi culture, grown in glucose-
containing HMI-9 was split at 0 h, +tet is induced with tetracycline,
while2tet is the non-induced control. (B) Specific activities of 6PGDH in
induced and control 6PGDHRNAi parasites. (C) Western blot showing
predominant co-localization of 6PGDH with the glycosomal marker
aldolase (fraction S), while a faint band can also be observed in the
cytosolic fraction P with the marker enolase. (D) Cell densities during
growth on different substrates. At t= 0 h, a 6PGDHRNAi culture grown
on glucose was split at 1?105 ml21 to HMI-9 with either glucose or
fructose, and in the absence and presence of tetracycline. Plotted cell
densities are cumulative, as 2tet cultures were split at 48 h to
1?105 ml21. A higher starting cell density was used to allow the
parasites to adapt to the change in carbon source. Growth on fructose
is slower than on glucose, but is unable to rescue the induced cultures.
doi:10.1371/journal.pcbi.1003371.g006
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loss in trypanosomes is not due to a catastrophic positive feedback
loop induced through PGI inhibition.
In vitro, 6PGDHRNAi had a slightly slower growth when glucose in
the medium was substituted with fructose (Figure 6C). However, in
common with model predictions, growth on fructose was unable to
rescue the lethal phenotype of 6PGDH ablation in the 6PGDHRNAi
cell line (Figure 6C). The fact that G6PDH is also essential for
bloodstream form T. brucei [11], whereas loss of this enzyme can
revert lethality associated with loss of 6PGDH inDrosophila [40] and
yeast [41], further indicates that it is loss of the oxidative branch of
the PPP per se in T. brucei that is responsible for death, rather than the
glycolysis inhibitory loop proposed in other eukaryotes.
Discussion
The mathematical model of glucose metabolism in the
bloodstream form trypanosome is among the most extensively
curated dynamic models of cellular metabolism. The model
accurately simulates a range of features of glucose metabolism in
the parasitic protist. In this paper, we extended this well curated
model of trypanosomal glycolysis with the PPP. However, in doing
so it soon becomes obvious that our knowledge of even this central
part of metabolism is incomplete. Using our previously established
strategy for explicitly handling uncertainty in dynamic models, and
additionally taking uncertainty on the metabolic network topology
into account, we are able to characterize important gaps in our
knowledge of trypanosomal metabolism, but we could also show
which behaviors are robust to the uncertainty.
The first type of solution to the observed phosphate ‘‘leak’’,
introduced upon extension of the glycolytic model with the PPP,
required the presence of additional enzymatic reactions within the
glycosome to recover bound phosphate. As an example of this type
of solution, glycosomal ribokinase added to the kinetic model was
able to restore the glycosomal phosphate balance by generating
ATP. Kinetic characterization of recombinant T. brucei ribokinase
showed that the enzyme could indeed work in the ribose production
direction (albeit far less effectively than in the opposite direction).
Various genetic mutants of ribokinase, however, subsequently
indicated that it is unlikely that only ribokinase is involved in
restoring the phosphate balance. The gene appears to be essential,
but the ribokinase enzyme is apparently present in vast excess since
no phenotype could be observed in cells in which the transcript had
been knocked down by RNA interference. Also, in cells where an
inducible copy of the gene is present in place of both endogenous
alleles, growth occurs even when the gene is switched ‘‘off’’,
presumably due to leaky expression. The essential role for small
amounts of ribokinase is unknown, but it seems unlikely to be the
sole enzyme capable of sustaining the bound-phosphate balance in
these cells. Given that the glycosome contains multiple pathways
beyond glycolysis and the PPP, such as purine salvage, pyrimidine
biosynthesis, and parts of the ether lipid, fatty acid and isoprenoid
metabolic pathways (Table S3), a highly redundant system could
provide a robust network to maintain phosphate balance.
A second type of solution to the bound-phosphate leak would
involve a flow of bound phosphates into and out of the glycosome.
As an example of this type of solution, addition of a theoretical
glycosomal ADP:ATP antiporter analogous to the adenine
nucleotide antiporter found in yeast peroxisomes [27] allowed
glycolysis and the oxidative branch of the PPP to operate in
concert, as shown by the modeling results. However, since no
genes encoding the necessary transporters have been identified,
experimental support of these model predictions is not possible at
this point. Another variant of this type of solution would involve
non-specific pores in the glycosomal membrane, working in
tandem with low levels of residual glycolytic enzyme activity in the
cytosol [46], but again without knowing which genes encode the
glycosomal membrane translocases we remain uncertain as to any
roles they might play.
Since the topology of the active metabolic network in the
glycosome remains uncertain, neither of the two types of solutions
models was discarded, and both models were used together to
probe aspects of the behavior of the glycolytic and pentose
phosphate pathways, expanding on the modeling strategy intro-
duced in [8]. Simulations of the two model types provided very
similar results; behavior under oxidative stress was nearly identical,
while the inhibition of 6PGDH only showed minor differences
between the two models, always taking into account the additional
uncertainty about the exact kinetic parameters of all enzymes
involved.
While the two types of model showed different behavior at very
low 6PGDH activities, both were able to exclude the initial
hypothesis that inhibition of PGI by accumulated 6-PG is the
explanation for the lethal effect of 6PGDH inhibition [10,38]. This
was verified experimentally when RNA interference confirmed
that loss of 6PGDH is lethal to cells and that this lethality is
retained when fructose is used as the carbon and energy source.
Since fructose enters the pathway after PGI, the feedback loop via
PGI, proposed to operate in other eukaryotes [39–42], cannot
explain lethality. A remaining possibility is that inhibition of
6PGDH renders the parasite more sensitive to oxidative stress, but
we could not test this given that knockdown of the gene is lethal.
In this article we demonstrate how building models of
metabolism can provide a powerful means to indicate where our
knowledge of the biological system is lacking. We can then
hypothesize possible solutions to these the gaps in our knowledge
and test these possible solutions, both in silico and experimentally.
Interestingly, even where uncertainties about the actual structure
of the system cannot be resolved for technical reasons and
experimental testing of the hypotheses is limited, explicit
consideration of the uncertainties during model construction and
analysis allows us to make meaningful predictions in the face of
limited information. This considerably extends the usefulness of
many dynamic models, as uncertainty can be levered as strength.
Materials and Methods
Stoichiometry
The computational model was constructed in a modular way.
The reactions included in each module are listed in Table 1 and
graphically represented in Figure 1. The starting point is a module
describing glycolysis in bloodstream form T. brucei [7,8]. A few
modifications in the kinetic equations are listed below. There are
two PPP modules, each consisting of an almost identical set of
reactions; one is localized entirely in the glycosomal matrix and
the other in the cytosol. To allow flux through the glycosomal PPP
the model has been further extended with either a ribokinase
module or an ATP:ADP antiporter across the glycosomal
membrane. The rationale behind these extensions is discussed in
the Results section.
Ribose 5-phosphate and ribose are modeled as end-products of
the PPP, depending on model version and compartment. As no
published intracellular concentrations are available for ribose 5-
phosphate and ribose, their cytosolic and glycosomal concentra-
tions were fixed at 0.01 mM unless stated otherwise.
Kinetic equations
Generic equations. Most of the rate equations follow the
generic form:
Modelling Metabolism in Trypanosoma brucei
PLOS Computational Biology | www.ploscompbiol.org 9 December 2013 | Volume 9 | Issue 12 | e1003371
vx,c=g~Vmax,c=g:
½S1c=g
Km,S1
: ½S2c=g
Km,S2
: 1{
Cx,c=g
Keq,x
 
1z
½S1c=g
Km,S1
z
½P1c=g
Km,P1
 
: 1z
½S2c=g
Km,S2
z
½P2c=g
Km,P2
  , ð1Þ
for reactions with two substrates and two products. Reactions with
only one substrate and product involved follow:
vx,c=g~Vmax,c=g:
½S1c=g
Km,S1
: 1{
Cx,c=g
Keq,x
 
1z
½S1c=g
Km,S1
z
½P1c=g
Km,P1
, ð2Þ
where x identifies the reaction, S1 and S2 are the substrates while
P1 and P2 are the products of the reaction. Subscripts c/g indicates
that separate equations are used for cytosolic and glycosomal
hexokinase. Keq is the standard equilibrium constant, and Cx,c/g
specifies the ratio of substrates and products and is defined as
Cx,c=g~
½P1c=g:½P2c=g
½S1c=g:½S2c=g
, ð3Þ
in Equation 1, and
Cx,c=g~
½Pc=g
½Sc=g
, ð4Þ
in Equation 2.
Modified glycolysis model. The glycolysis module has been
modified as compared to the latest version [7,8] by using reversible
rate equations for hexokinase (HXK), phosphofructokinase (PFK)
and pyruvate kinase (PYK), which were modeled previously as
irreversible reactions. Hexokinase now follows Equation 1 and 3.
PFK is modeled with reversible ordered bi-bi kinetics with
mixed inhibition by fructose 1,6-bisphosphate [47]:
vPFK,g~Vmax,g
: Kii
½Fru-1,6-BPgzKii
:
½Fru-6-Pg
Km,Fru-6-P
: ½ATPg
Km,ATP
: 1{
CPFK,g
Keq,PFK
 
Ks,ATP
Km,ATP
z
½ATPg
Km,ATP
z
½Fru-6-Pg
Km,Fru-6-P
z
½Fru-6-Pg :½ATPg
Km,Fru-6-P
:
Km,ATP
z
½ADPg
Km,ADP
z
½Fru-1,6-BPg :½ADPg
Kis
:
Km,ADP
,
ð5Þ
where CPFK,g follows Equation 3, Kii and Kis describe the mixed
inhibition by fructose 1,6-bisphosphate and are also taken from [47].
Pyruvate kinase is modeled reversibly with cooperativity for PEP:
vPK,c~
Vmax,c:
½PEPc
KPEP
 n
: ½ADPc
Km,ADP
: 1{
CPK,c
Keq,PK
 
1z
½PEPc
KPEP
 n
z
½Pyrc
Km,Pyr
 
: 1z
½ADPc
Km,ADP
z
½ATPc
Km,ATP
  ð6Þ
where CPK,c has again the same meaning as in Equation 3, and
KPEP~Km,PEP: 1z
½ATPc
Ki,ADP
z
½ADPc
Ki,ADP
 
: ð7Þ
Phosphoglucose isomerase. The known inhibition of
phosphoglucose isomerase (PGI) by the PPP intermediate 6-
phosphogluconate (6-PG) was included as described in [43]:
vPGI,g~Vmax,g:
½Glc-6-Pg
Km,Glc-6-P
: 1{
CPGI,c
Keq,PGI
 
1z
½Glc-6-Pg
Km,Glc-6-P
z
½Fru-6-Pg
Km,Fru-6-P
z
½6-PGg
Ki,6-PG
ð8Þ
where CPGI,g follows equation 4.
ATP:ADP antiporter, G6PDH, 6PGDH, PPI, RK,
TR. Most of the reversible reactions of the pentose phosphate
pathway were modeled according to Equations 1–4, dependent on
the number of substrates and products. For the ATP:ADP
antiporter the substrates S1 and S2 are ATPc and ADPg and the
products P1 and P2 are ATPg and ADPc.
Phosphogluconolactonase. For the 6-phosphogluconolacto-
nase (PGL) reaction, the spontaneous hydrolysis as well as the
enzyme-catalyzed rate were included [48]:
vPGL,c=g~Vmax,c=g:
½6-PGLc=g
Km,6-PGL
: 1{
CPGL,c
Keq,PGL
 
1z
½6-PGLc=g
Km,6-PGL
z
½6-PGc=g
Km,6-PG
zk:Vc=g: ½6-PGLc=g{
½6-PGc=g
Keq,PGL
 
ð9Þ
where k is the rate of spontaneous hydrolysis and Vc/g is the volume
of the relevant compartment, which are 5.4549 and 0.2451 mL per
mg protein for the cytosol and glycosome, respectively.
Glc-6-P utilization. The Glc-6-P utilization reaction was
modeled as loss of Glc-6-P to glucose through a hypothetical
phosphatase reaction, using Equations 2 and 4. Other fates of Glc-6-
P, such as entry into inositol metabolism and mannose glycocon-
jugate biosynthesis, for which kinetic parameters are not known, are
also covered by this generic Glc-6-P consuming reaction.
NADPH utilization and trypanothione oxidation reactions
(TOX). Glycosomal and cytosolic oxidation of NADPH and
trypanothione are modeled with mass action kinetics:
vx,c=g~kx:½NADPHc=g ð10Þ
where kx is the mass-action constant of reaction x.
Kinetic parameters
The kinetic parameters in the rate equations mentioned above
were predominantly derived from literature. If no parameters of
the T. brucei enzyme were available, parameters from related
species were used. If necessary, Keq values were corrected to pH 7.
Kinetic parameters used in the fixed parameter model are listed in
Table S1. Distributions of parameters used in uncertainty
modeling are given in Text S1.
Metabolite concentrations
The extension of the model with the glycosomal pentose
phosphate pathway led to an extension of the conserved moiety of
phosphorylated glycosomal metabolites as compared to earlier
model versions [4]. For a precise overview of conserved moieties in
each model version see Table 2. The new conserved sum was
chosen such that extension of the glycolysis model with the
glycosomal PPP and ribokinase results in similar steady state
concentrations of glycolytic metabolites in both models. The
conserved sum of NADPH in the cytosol and glycosome was
arbitrarily chosen as 2 mM, while the conserved sum of
trypanothione was chosen as 0.38 mM [12]. In the models
(5)
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including fructose transport, cytosolic Fru-6-P was fixed to the
measured steady-state value of 0.9 mM, as additional reactions in
the cytosol that are not included in the model would consume Fru-
6-P. Inorganic phosphate (Pi) is not explicitly included in the
model, as it is assumed to be present at saturating levels and
regulated independently of glycolysis.
Calculations and simulations
The model was initially constructed and simulations were
performed in PySCeS 0.7.8 [49] or COPASI 4.8 [50]. SBML
versions of the models are supplied as Dataset S1. The models in
this paper have additionally been modeled while taking uncer-
tainty into account as described in [8]. Each simulation exists of
1000 individual runs, where in each run all parameter values are
sampled simultaneously. The 6PGDH Vmax scans of Figures 5 and
S5, S6, S7, S8 show 250 simulations, as the longer time-limit and
accumulating metabolites greatly increased the time for the
simulation to finish (a week on a desktop PC for model D). The
parameter distributions are described in more detail in Text S1,
while the parameter sets are provided as Dataset S2, S3.
Expression recombinant ribokinase
The T. brucei ribokinase gene (GenBank ID:3664382) was
amplified from Lister 427 strain T. brucei genomic DNA and
cloned into plasmid pET28a(+) (Novagen) to add an N-terminal
His-tag. The protein was overexpressed in E. coli BL21(DE3),
purified by Ni2+ chelate chromatography and dialyzed in 50 mM
Tris-HCl pH 7.0, 100 mM NaCl, 20% glycerol. Purity was
assessed by SDS-PAGE and Coomassie blue staining.
Enzyme activity assays
Activity of ribokinase was assayed at 25uC in buffer containing
10 mM KH2PO4, 15 mM NaCl, 85 mM KCl and 10 mMMgCl2
at pH 7. Ribokinase activity in the direction of ribose 5-phosphate
production was assayed spectrophotometrically according to [51],
with 5 mM ribose, 5 mM phosphoenolpyruvate, 5 mM ATP,
0.2 mM NADH, 5 u PK and 5 u LDH. Ribokinase activity in the
direction of ribose production was assayed spectrophotometrically
with 5 mM ribose 5-phosphate, 5 mM glucose, 5 mM ADP,
0.2 mM NADP, 5 u HXK and 5 u G6PDH.
Parasites and genetic mutants
Bloodstream form Lister 427 strain T. brucei parasites were
routinely cultured in HMI-9 [52] at 37uC and 5% CO2. For growth
of 6PGDHRNAi on an alternative hexose source, glucose in HMI-9
was substituted with fructose at the same concentration. Antibiotic
concentrations for genetic mutants were: 0.5 mg mL21 phleomycin
and 2.5 mg mL21 hygromycin for RKRNAi; 0.5 mg mL21 phleo-
mycin, 5 mg mL21 G418 and 10 mg mL21 hygromycin for
6PGDHRNAi; 0.5 mg mL21 puromycin for DRK::PAC/RK;
2.5 mg mL21 hygromycin for DRK::HYG/RK and 0.5 mg mL21
puromycin, 2.5 mg mL21 hygromycin, 0.5 mg mL21 phleomycin
and 2 mg mL21 blasticidin for DRK::HYG/PAC::RKtet. Sensitivity
of T. brucei to ribose was assayed with alamarBlue as described
previously [53].
The ribokinase knockdown cell line RKRNAi was generated
using the pRPaiSL vector/2T1 cell line system [54], while the 6-
phosphogluconate dehydrogenase (Tb427tmp.211.3180) knock-
down cell line 6PGDHRNAi was generated using the p2T7 vector/
1313 cell line system [55]. The generation of the ribokinase
knockout cell line DRK::HYG/PAC was attempted using
constructs containing 600 bp 59 and 39 UTRs adjacent to the
ribokinase gene, cloned into vector pTBT [56], flanking either a
hygromycin phosphotransferase or puromycin N-acetyl-transferase
gene as antibiotic resistance markers. The tetracycline-inducible
expression of ribokinase in the conditional knockout DRK::HYG/
PAC::RKtet was generated by cloning the ribokinase coding
sequence in pHD1336 and using cell line 449 (kind gifts by Prof
Christine Clayton, Heidelberg). Parasites were transfected by
Amaxa nucleofection (Lonza) [57] using Tb-BSF buffer [58], and
plated out by limiting serial dilution.
Western blotting
Polyclonal antibodies against T. brucei ribokinase were raised in
rabbits by injection of purified recombinant T. brucei ribokinase,
purified by protein A-chromatography, and an antibody titer of
.1:192,000 was measured by ELISA (GenicBio, Shanghai,
China). The anti-serum was further purified by immunoaffinity
chromatography. Recombinant T. brucei ribokinase was coupled to
a mixture of Affi-Gel 10 and 15 (Bio-Rad). Antibodies were eluted
from the column with 3.5 M MgCl2. Polyclonal antibodies against
the T. brucei 6PGDH were raised in rats by infection of purified
recombinant T. brucei 6PGDH.
For protein samples, 5?106 cells were harvested by centrifugation
and washed with PBS. Samples were separated on NuPAGE 4–
12% Bis-Tris precast gels (Life Technologies) for 45 min at 200 V
and transferred to a nitrocellulose membrane (Hybond-ECL,
Amersham) at 100 V for 2 h. Membranes were blocked overnight
at 4uCwith 5%milk in PBS-T (PBS with 0.05%Tween-20), washed
three times with PBS-T, and probed with the purified polyclonal
rabbit anti-T. brucei ribokinase antibody, diluted 1:2000 in 1% milk
in PBS-T, for 4 h at room temperature. After three additional
washes with PBS-T, the membrane was incubated with the
secondary antibody (goat anti-rabbit IgG peroxidase conjugate,
Calbiochem) 1:2000 in 1% milk in PBS-T for 2 h at room
temperature. After five washes with PBS-T, horseradish peroxidase
activity was measured with SuperSignal HRP substrate (Novagen).
Subcellular localization of 6PGDH in trypanosomes was
performed by modification of the digitonin fractionation method
described in [59]. Specifically, 5?107 procyclic cells were washed
with STEN buffer (250 mM sucrose; 25 mM Tris-HCl, pH 7.5;
1 mM EDTA and 150 mM NaCl) and resuspended in 300 mL
STEN supplemented with protease inhibitors (Roche). The cells
were differentially permeabilized with 40 mg digitonin per 100 mg
cellular protein (2.5?107 cells) for 2 hours on ice and centrifuged at
16,000 g for two minutes. After TCA precipitation, equal amounts
(equivalent of 4?106 cells) of the supernatant (S) and pellet (P) were
analyzed by SDS-PAGE and blotted with rat anti-Tb6PGDH. A
goat anti-rabbit IgG peroxidase was used for visualization as
described for ribokinase. Enolase and aldolase were used as
cytosolic and glycosomal markers, respectively, and antibodies
against these proteins were kindly provided by Prof. Paul Michels
(University of Louvain, Belgium).
Supporting Information
Dataset S1 SBML versions of models. SBML versions of
the models presented in Figure 1.
(ZIP)
Dataset S2 Parameter sets used for simulations of
models A–D. Sets of parameter values as sampled from the
distributions described in Text S1, as used for simulations of
models A–D during growth on glucose.
(CSV)
Dataset S3 Parameter sets used for simulations of
models Cfru and Dfru. Sets of parameter values as sampled
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from the distributions described in Text S1, as used for simulations
of models Cfru and Dfru.
(CSV)
Figure S1 Enzymes of purine salvage pathway localized
in glycosome. The glycosomal PPP is shown with those enzymes
from the purine salvage pathway that have a predicted glycosomal
localization (Table S3). Reactions from the PPPmodel are indicated
by their number from Table 1, while the additional reactions are
indicated as: PRPP: phosphoribosyl pyrophosphate synthetase;
AdK: adenosine kinase; ANase: adenosine nucleosidase; APRT:
adenine phosphoribosyltransferase. Metabolites that are not
balanced within this pathway are indicated in bold. The scheme
demonstrates how the presence of the purine salvage pathway is
unable to rescue the phosphate leak, as the resulting overall reaction
is glucose+ATPRribose+AMP+PPi (+CO2, implied to be balanced
with gaseous CO2). Additional ADK and ANase reactions does not
improve this situation, with a resulting overall reaction of
glucose+ADPR2 ribose+adenine+2 PPi (+CO2). In contrast,
ribokinase is capable of resolving the phosphate leak with a
resulting overall reaction of glucoseRribose (+CO2).
(TIF)
Figure S2 Steady-state fluxes through various models.
Steady state fluxes of at standard conditions (green, kTOX=2 ml?-
min21?mg protein21) and if cytosolic PPP is maximized (red,
kTOX=200 ml?min
21?mg protein21). Error bars indicate inter-
quartile ranges. NA denotes ‘Not Applicable’ for branches that are
absent from certain model version, Glce is 5 mM in all models.
The glucose consumption flux is distributed over the production of
glycerol and pyruvate and the two branches of the PPP. Note that
ALD generates two trioses from every hexose, such that the fluxes
through the trioses glycerol and pyruvate are double the hexose
flux. The errors bars indicated interquartile ranges as a result of
the uncertainty modelling. The large error bars for glycerol
production are a result of its low flux and the smaller uncertainties
assigned to the fluxes through the other pathways. No information
is given for model B, as this model is incomplete and cannot reach
a steady state (outlined in the main text).
(TIF)
Figure S3 Genetic investigations in T. brucei riboki-
nase. (A) Northern blot of RKRNAi induced and non-induced T.
brucei, samples taken 24, 48 and 72 hours post induction by
tetracycline. Tubulin was used as loading control. (B) Western blot
of RKRNAi and Drk::HYG/PAC::RKtet, samples taken at t=0, 1,
2 and 3 days post induction by tetracycline. (C) Growth curve of
ribokinase knockdown mutant by RNA interference. Induction of
RNAi was started at t = 0 by the addition of 1 mg/mL tetracycline.
Cell densities of induced (dotted line) and control (solid line)
cultures were determined by cell counts, and cultures were diluted
down to 2?104 cells ml21 at t=48 and 96 h. No difference in
growth effect could be observed. (D) Successful transfection of T.
brucei with knockout constructs was confirmed by PCR.
(TIF)
Figure S4 Ribose sensitivity. Steady state concentrations (A)
and fluxes (B) of model C at various concentrations of ribose. Solid
lines indicate medians, shaded areas show interquartile ranges.
Increasing ribose concentration results in a depletion of ATP and
accumulation of ribose 5-phosphate in the glycosome. While the
glycosomal PPP flux (JG6PDHg) remains mostly unaffected, the
glycolytic flux (JPGI) is strongly reduced.
(TIF)
Figure S5 Simulations of oxidative stress in model D.
Near identical to Figure 4, with results of model D instead. (A) The
steady state flux through the cytosolic pentose phosphate pathway
in model D as a function of the oxidative stress by varying the
kinetic constant kTOX. (B) Fluxes through the cytosolic PPP
enzymes as a function of time upon sudden oxidative stress.
During the whole time-course, kTOX=2 ml?min
21?mg protein21.
The system is removed from steady state at t=0, by setting 99% of
the NAD(P)H and trypanothione pools to the oxidized form.
Shown is the relaxation of the cytosolic PPP fluxes. Solid lines
indicate medians, shaded areas show interquartile ranges.
(TIF)
Figure S6 Simulations of 6PGDH inhibition and 6-PG
accumulation. (A–B) The effects of inhibition of 6PGDH on 6-
PG concentrations and metabolic fluxes were simulated by
reducing Vmax,6PGDH in model C and D at low oxidative stress
(kTOX=2 ml?min
21?mg protein21). Results for simulations at low
oxidative stress (kTOX=200 ml?min
21?mg protein21) are shown in
Figure 5. ATP production flux as steady-state flux through PFK is
indicated in red, while trypanothione reductase steady-state flux is
indicated in yellow, both plotted on the left y-axis. Steady-state
concentration of cytosolic (blue) and glycosomal (green) 6-
phosphogluconate are plotted on the right y-axis. Shaded areas
indicate interquartile ranges.
(TIF)
Figure S7 Simulations of 6PGDH inhibition during
growth on fructose. (A–B) The effects of inhibition of 6PGDH
on 6-PG concentrations and metabolic fluxes were simulated by
reducing Vmax,6PGDH in model C and D at high oxidative stress
(kTOX=200 ml?min
21?mg protein21), similar to Figure 5. ATP
production flux as steady-state flux through PFK is indicated in
red, while trypanothione reductase steady-state flux is indicated in
yellow, both plotted on the left y-axis. Steady-state concentration
of cytosolic (blue) and glycosomal (green) 6-phosphogluconate are
plotted on the right y-axis. Shaded areas indicate interquartile
ranges.
(TIF)
Figure S8 Percentage of models reaching steady-state within 10
million simulation minutes during 6PGDH inhibitions. As
explained in detail in Text S1, 250 random parameter sets were
used for calculating steady-states during 6PGDH inhibition
(Figures 5 and S5). Outcome of model C are shown at high (A)
and low (B) oxidative stress; and in model D at high (C) and low (D)
oxidative stress. Panel A and C correspond to Figures 5A–B, while
panel B and D correspond to Figures S6A–B.
(TIF)
Figure S9 Percentage of models reaching steady-state within 10
million simulation minutes during 6PGDH inhibitions with
growth on fructose. As explained in detail in Text S1, 250
random parameter sets were used for calculating steady-states
during 6PGDH inhibition (Figures 6 and S6). Outcome at high
oxidative stress are shown for model C (A) and D (B). Results from
the simulations are shown in Figure S7.
(TIF)
Table S1 Kinetic parameters of the enzymes related to the PPP.
Activities, which depend on the expression level of the enzymes, are
specified separately for the fraction of the enzyme that is localized in
the glycosome and, if applicable, for the fraction which is located in
the cytosol. c/g indicates that cytosolic and glycosomal activities are
identical. Other parameters are assumed to be identical for
glycosomal and cytosolic enzyme fractions. Parameter values given
here are used in the fixed parameter models. Distributions of
parameter values used in uncertainty modelling are given in Text S1.
(DOCX)
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Table S2 Elementary flux modes in models of PPP. The
elementary modes of different model versions including the
glycosomal PPP are listed as the overall reactions plus in brackets
the individual enzyme-catalyzed reactions with their relative flux
weight. For simplicity the cytosolic PPP and the cytosolic NADPH
utilization were left out of this analysis. The modules included in
each model version refer to Table 1 and the color-coded
extensions in Figure 1 in the main text. A negative number
indicates that the reaction occurs in the reverse direction as
compared to Table 1 in the main text. The order of reactions
corresponds to that in Table 1 in the main text. The glycolytic
modes 1–3 are possible in all model versions, but are not listed
again for the model versions extended with the glycosomal PPP.
Elementary mode analysis of model B only results in the flux
modes 1–3.
(DOCX)
Table S3 Predicted glycosomal proteome. All reactions
present in the bloodstream form T. brucei glycosome, according to
comprehensible glycosomal proteomics [18,19]. Only reactions
present in the bloodstream form of the parasite are included.
Abbreviations and EC numbers are given for each reaction.
Models are indicated where reactions are part of a model in the
main text. Indicated are what reactions are part of an elementary
model (see Table S4).
(DOCX)
Table S4 Elementary modes in glycosomal proteome. A
model of glycosomal metabolism was constructed for use in
METATOOL version 4.9.3 [60]. The reactions from Table S3
were used. All reactions were set as reversible, except for
alternative oxidase (TAO), phosphofructokinase (PFK), fructose
bisphosphatase (FBPase), and phosphogluconolactonase (PGL).
Protons, Pi, PPi, H2O, CO2 and O2 were not included in the
reactions. Glucose, 3-phosphoglyceric acid, ribose and glycerol
were set as external metabolites. The resulting model has 9
elementary modes, where the first four modes are also occurring in
the models described in this paper. Elementary mode 5 is a futile
cycle without external metabolites involved. Elementary modes 6–
9 are unlikely to occur in dividing bloodstream trypanosomes, as a
high glucose to pyruvate and glycerol flux is maintained.
Additionally, the activity of fructose bisphosphatase could not be
measured [23,61].
(DOCX)
Text S1 Uncertainty modeling and distribution of
parameter values. Detailed description of the methodology
for uncertainty modeling and distributions defined for sampling of
random parameter values.
(DOCX)
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